Pavinetant clinical trials
Also written AZD2624.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses pavinetant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
AstraZeneca (4) · Millendo Therapeutics US, Inc. (1)
Studies
Open first, then newest update. How each study uses pavinetant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- MLE4901 vs. Placebo for the Treatment of PCOSTerminatedPhase 2Millendo Therapeutics US, Inc.NCT02865915Written as MLE4901
- A Study of AZD4901 in Females With Polycystic Ovary SyndromeCompletedPhase 2AstraZenecaNCT01872078Written as AZD4901 (oral)
- Phase IIA Study in Patients With SchizophreniaCompletedPhase 2AstraZenecaNCT00686998Written as AZD2624
- AZD2624 Multiple Ascending Dose Study in JapanCompletedPhase 1AstraZenecaNCT00696865Written as AZD2624
- Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet FormulationCompletedPhase 1AstraZenecaNCT00867685Written as AZD2624
Codes
What other systems call pavinetant · ClinicalTrials.gg INT005768
- UNII (FDA) 3U471ZVC5KPAVINETANTConfirmed FDA, Wikidata
- Wikidata Q27074725pavinetantConfirmed FDA, Wikidata
- NCI Thesaurus C166698PavinetantOne source FDA
- DrugBank DB11692One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 3U471ZVC5K | PAVINETANT | Confirmed FDA, Wikidata |
| Wikidata | Q27074725 | pavinetant | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166698 | Pavinetant | One source FDA |
| DrugBank | DB11692 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.